An interventional study of Three dimensional maxillary bone augmentation in Atrophic Maxilla, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to participants aged 20 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-06-01.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Assessment of bone quality and quantity for three dimensional bone augmentation for maxilla using titanium meshes loaded with bone marrow aspirate mixed with xenograft versus xenograft mixed with autografts only
828 studies on the registry are indexed under Atrophy; 122 are open to participants now.
This study's planned enrollment of 20 is below the median of 34 across 603 interventional studies indexed under Atrophy.
Browse Atrophy studies →Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients are free from any systemic conditions and bone metabolic diseases that might interfere with the surgical intervention, soft tissue or hard tissue healing.
Exclusion Criteria:
Intra-bony lesions (e.g. cysts) or infections (e.g. abscess) that may retard the osteotomy healing.
Procedure: Three dimensional maxillary bone augmentation
Procedure: Three dimensional maxillary bone augmentation
mixing of bone marrow aspirate concentrate with xenograft to show the bone quality and bone gain compared to the xenografts mixed with autografts
Histomorphometric bone analysis
ratio of mineralized tissue to non mineralized tissue
Time frame: 4 months
Alveolar ridge vertical bone and horizontal bone gain
Gain measured in millimeters on a cone beam computed tomograpghy
Time frame: 4 months
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University